Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel/Capecitabine and Celecoxib Followed by Doxorubicin/Cyclophosphamide and Celecoxib in Breast Cancer
NCT00665457Phase 2Terminated
- Sponsor
- University of Nebraska
- Start
- Apr 2004
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in breast cancer, sponsored by University of Nebraska. Started Apr 2004; status: terminated.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00665457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00665457.